Sheffer, Albert L <br/><br/>
Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks.  [electronic resource] 

 -  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology  Mar 2013 
 - 184-188.e2 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1534-4436 
<br/><br/><label>Standard No.: </label>10.1016/j.anai.2012.12.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anaphylaxis--drug therapy<br/>Angioedemas, Hereditary--drug therapy<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Disease Progression<br/>Epinephrine--therapeutic use<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Larynx--drug effects<br/>Male<br/>Middle Aged<br/>Peptides--administration & dosage<br/>Risk<br/>Treatment Outcome<br/>Young Adult